| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/01/2002 | US20020103149 An isolated nucleic acid molecule encoding a novel varient of vascular endothelial growth factor; vectors and host cells and reactive antibodies; controlling neovascularization; antitumor, - carcinogenic agents |
| 08/01/2002 | US20020103148 Vectors comprising SAR elements |
| 08/01/2002 | US20020103147 Enhancing cardiac function in a mammal by delivering to the heart a vector comprising a gene encoding a beta-adrenergic signaling protein (beta-ASP) operably linked to a promoter; using a recombinant viral vector replication-defective |
| 08/01/2002 | US20020103142 Protective, interactive, non-condensing compounds used to prolong localized bioavailability and enhancing expression of a nucleic acid; anticancer agents |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell |
| 08/01/2002 | US20020103112 Wound healing and treatment of fibrosis |
| 08/01/2002 | US20020102732 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/01/2002 | US20020102731 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 08/01/2002 | US20020102729 Formulations for electroporation |
| 08/01/2002 | US20020102728 Generating cells for treating osteoporosis and osteoarthritis; obtain cells, transform cell with vector coding bone morphogenic protein, recover transformed cells, culture cells |
| 08/01/2002 | US20020102722 Lac shuttle vectors |
| 08/01/2002 | US20020102714 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102694 Nucleozymes with endonuclease activity |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102683 Nucleotide sequences coding enzymatic polypeptide for use in human therapeutics, cosmetics, nutrients and pharmacology |
| 08/01/2002 | US20020102679 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
| 08/01/2002 | US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer |
| 08/01/2002 | US20020102609 Antagonists of HMG1 for treating inflammatory conditions |
| 08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 08/01/2002 | US20020102550 Detection of blooms disease; obtain tissue sample, incubate with probe which hybridizes to gene associated with blooms disease, the abence of wildtype gene indicates disease |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102267 CLASP-5 transmembrane protein |
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102248 Modulating response to genotoxic stress |
| 08/01/2002 | US20020102247 For therapy of hyperproliferative disorders |
| 08/01/2002 | US20020102245 14-3-3sigma arrests the cell cycle |
| 08/01/2002 | US20020102244 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell |
| 08/01/2002 | US20020102241 Useful for the regeneration of damaged kidney tissue, the generation of artificial kidneys and the delivery of transgenes |
| 08/01/2002 | DE10103695A1 Verwendung von Sialyltransferasen für die Diagnose und Therapie von Tumorerkrankungen Sialyltransferases of use in the diagnosis and therapy of tumor diseases |
| 08/01/2002 | CA2436076A1 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | CA2435949A1 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435672A1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | CA2435631A1 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo |
| 08/01/2002 | CA2434320A1 Chemokines as adjuvants of immune response |
| 08/01/2002 | CA2433867A1 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 08/01/2002 | CA2432991A1 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | CA2432276A1 Regulation of cell growth by muc1 |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2431313A1 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | CA2431177A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | CA2429034A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 08/01/2002 | CA2427061A1 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | CA2425149A1 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents |
| 07/31/2002 | EP1227324A2 Har A polypeptides and nucleic acids and related methods and uses thereof |
| 07/31/2002 | EP1227147A2 Recombinational cloning using engineered recombination sites |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226438A1 Composite nanospheres and their conjugates with biomolecules |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226279A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 07/31/2002 | EP1226264A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/31/2002 | EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 07/31/2002 | EP1226254A2 Virulence genes, proteins, and their use |
| 07/31/2002 | EP1226253A2 Neisserial antigenic peptides |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226242A1 Human cub-domain-containing protein and gene encoding the same |
| 07/31/2002 | EP1226238A2 Method for creating divergent populations of nucleic acid molecules and proteins |
| 07/31/2002 | EP1226233A2 Multipotent adult stem cells and methods for isolation |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226170A2 Human proteins and polynucleotides encoding the same |
| 07/31/2002 | EP1226168A1 Ligand activated transcriptional regulator proteins |
| 07/31/2002 | EP1226151A2 Gene expression directed by a super-psa promoter |
| 07/31/2002 | EP1226150A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225921A1 TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
| 07/31/2002 | EP1225920A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 07/31/2002 | EP1225919A1 Treatment of cancer |
| 07/31/2002 | EP1225912A1 A method of prophylaxis and treatment |
| 07/31/2002 | EP1225909A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 07/31/2002 | EP1225846A2 Bioprosthetic heart valves |
| 07/31/2002 | EP1225801A1 Propagation of human hepatocytes in non-human animals |
| 07/31/2002 | EP0850244B1 Toxoplasma gondii glycoconjugates |
| 07/31/2002 | EP0825873B1 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 07/31/2002 | EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | CN1361825A Novel antifungal agents and fungicides method for the production thereof and their use |
| 07/31/2002 | CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 07/31/2002 | CN1361822A Reg-binding protein |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/31/2002 | CN1361681A Methods for preparation of lipid-encapsulated therapeutic agents |
| 07/31/2002 | CN1361285A Pyocyanine gene and target gene therapy of cancer with its packing and guiding protein composite |
| 07/31/2002 | CN1361244A Discovered chronic granulocyte leukosis related stem and ancestral cell molecule |
| 07/31/2002 | CN1361131A Enhanced internal translation factor of eukaryotic cell and its use |
| 07/30/2002 | US6426412 Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements |
| 07/30/2002 | US6426411 PGC-1, a novel brown fat pparγ coactivator |
| 07/30/2002 | US6426405 Therapeutic target for treatment of diseases associated with altered muscle activity of pain transmission; has properties of glycine transporter associated with strychnine sensitive glycine receptors--properties called ?sc6? activity |
| 07/30/2002 | US6426336 Method for treating allergic lung disease |
| 07/30/2002 | US6426334 Administering nucleotide sequence |
| 07/30/2002 | US6426208 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |